Live feed16:05:03·5mINSIDERFilingvia QuantisnowChief Executive Officer Ceesay Abraham sold $937,957 worth of shares (18,921 units at $49.57) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 467,187 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.RAPP· Rapport Therapeutics Inc.Health CareOriginal source
